Screening the General Population for SARS-CoV-2 Virus and COVID-19 Antibodies: A Counterargument.
作者信息
Wu Alan H B
机构信息
Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA.
出版信息
J Appl Lab Med. 2020 Sep 1;5(5):1107-1110. doi: 10.1093/jalm/jfaa104.
Abstract
摘要
相似文献
1
Screening the General Population for SARS-CoV-2 Virus and COVID-19 Antibodies: A Counterargument.对普通人群进行新冠病毒（SARS-CoV-2）和新冠病毒病（COVID-19）抗体筛查：一种反对观点。
J Appl Lab Med. 2020 Sep 1;5(5):1107-1110. doi: 10.1093/jalm/jfaa104.
2
The explosion of new coronavirus tests that could help to end the pandemic.新型冠状病毒检测的激增可能有助于终结这场大流行。
Nature. 2020 Jul;583(7817):506-509. doi: 10.1038/d41586-020-02140-8.
3
AGA Institute Rapid Review and Recommendations on the Role of Pre-Procedure SARS-CoV-2 Testing and Endoscopy.美国胃肠病学会关于术前新型冠状病毒2检测与内镜检查作用的快速回顾及建议
Gastroenterology. 2020 Nov;159(5):1935-1948.e5. doi: 10.1053/j.gastro.2020.07.043. Epub 2020 Jul 28.
4
Risk assessment of outpatient dermatology practice in the setting of the COVID-19 pandemic.2019冠状病毒病大流行背景下门诊皮肤科诊疗的风险评估
J Am Acad Dermatol. 2020 Nov;83(5):1538-1539. doi: 10.1016/j.jaad.2020.07.035. Epub 2020 Jul 16.
5
Diagnostic Tests for SARS-CoV-2: Implications in Head and Neck Oncology.用于 SARS-CoV-2 的诊断检测：对头颈肿瘤学的影响。
Oral Oncol. 2020 Aug;107:104813. doi: 10.1016/j.oraloncology.2020.104813. Epub 2020 May 21.
6
Outcomes of Universal Preprocedure Coronavirus Disease 2019 Testing Before Endoscopy in a Tertiary Care Center in New York City.纽约市一家三级医疗中心在内镜检查前对所有患者进行2019冠状病毒病普遍检测的结果。
Gastroenterology. 2020 Nov;159(5):1962-1964. doi: 10.1053/j.gastro.2020.07.015. Epub 2020 Jul 16.
7
Perspective on oral exfoliative cytology and COVID-19.口腔脱落细胞学与新型冠状病毒肺炎的展望
Oral Oncol. 2020 Aug;107:104858. doi: 10.1016/j.oraloncology.2020.104858. Epub 2020 Jun 12.
8
SARS-CoV-2 infection among asymptomatic homebound subjects in Milan, Italy.意大利米兰居家无症状受试者中的新型冠状病毒2型感染情况。
Eur J Intern Med. 2020 Aug;78:161-163. doi: 10.1016/j.ejim.2020.06.010. Epub 2020 Jun 9.
9
People power: How India is attempting to slow the coronavirus.人民的力量：印度如何试图减缓新冠病毒的传播。
Nature. 2020 Apr;580(7804):442. doi: 10.1038/d41586-020-01058-5.
10
Comparison of serologic and molecular SARS-CoV 2 results in a large cohort in Southern Tuscany demonstrates a role for serologic testing to increase diagnostic sensitivity.在托斯卡纳南部的一个大型队列中比较血清学和分子 SARS-CoV-2 结果表明，血清学检测可提高诊断灵敏度。
Clin Biochem. 2020 Oct;84:87-92. doi: 10.1016/j.clinbiochem.2020.07.002. Epub 2020 Jul 21.
引用本文的文献
1
Mass Screening of SARS-CoV-2 With Rapid Antigen Tests in a Receding Omicron Wave: Population-Based Survey for Epidemiologic Evaluation.在奥密克戎波消退期间使用快速抗原检测进行 SARS-CoV-2 大规模筛查：用于流行病学评估的基于人群的调查。
JMIR Public Health Surveill. 2022 Nov 9;8(11):e40175. doi: 10.2196/40175.
2
How Can Nursing Teams Respond to Large-Scale COVID-19 Screening?护理团队如何应对大规模的 COVID-19 筛查？
Front Public Health. 2021 Oct 29;9:681255. doi: 10.3389/fpubh.2021.681255. eCollection 2021.
3
Practical Considerations for Implementation of SARS-CoV-2 Serological Testing in the Clinical Laboratory: Experience at an Academic Medical Center.临床实验室开展新型冠状病毒2型血清学检测的实践考量：一所学术医疗中心的经验
Acad Pathol. 2021 Apr 7;8:23742895211002802. doi: 10.1177/23742895211002802. eCollection 2021 Jan-Dec.
4
Current and innovative methods for the diagnosis of COVID‑19 infection (Review).目前用于 COVID-19 感染诊断的创新方法（综述）。
Int J Mol Med. 2021 Jun;47(6). doi: 10.3892/ijmm.2021.4933. Epub 2021 Apr 13.
5
Clinical Ordering Practices of the SARS-CoV-2 Antibody Test at a Large Academic Medical Center.一家大型学术医疗中心的新冠病毒 2 型抗体检测临床医嘱实践
Open Forum Infect Dis. 2020 Oct 9;7(10):ofaa406. doi: 10.1093/ofid/ofaa406. eCollection 2020 Oct.
本文引用的文献
1
An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment.评估 COVID-19 血清学检测有助于未来的诊断和暴露评估。
Nat Commun. 2020 Jul 6;11(1):3436. doi: 10.1038/s41467-020-17317-y.
2
Comparison of Abbott ID Now, DiaSorin Simplexa, and CDC FDA Emergency Use Authorization Methods for the Detection of SARS-CoV-2 from Nasopharyngeal and Nasal Swabs from Individuals Diagnosed with COVID-19.雅培ID Now、索林集团Simplexa以及美国疾病控制与预防中心（CDC）和美国食品药品监督管理局（FDA）紧急使用授权方法用于从确诊为COVID-19的个体的鼻咽拭子和鼻拭子中检测严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的比较
J Clin Microbiol. 2020 Jul 23;58(8). doi: 10.1128/JCM.00760-20.
3
Beware of the second wave of COVID-19.谨防新冠疫情第二波来袭。
Lancet. 2020 Apr 25;395(10233):1321-1322. doi: 10.1016/S0140-6736(20)30845-X. Epub 2020 Apr 8.
4
Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine.鉴定 2019 新型冠状病毒的受体结合域（RBD）：作为病毒附着抑制剂和疫苗开发 RBD 蛋白的意义。
Cell Mol Immunol. 2020 Jun;17(6):613-620. doi: 10.1038/s41423-020-0400-4. Epub 2020 Mar 19.
5
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.严重急性呼吸综合征冠状病毒 2 型（SARS-CoV-2）进入细胞依赖于 ACE2 和 TMPRSS2，可被一种临床验证的蛋白酶抑制剂所阻断。
Cell. 2020 Apr 16;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020 Mar 5.
6
Correlation of Chest CT and RT-PCR Testing for Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases.中国 2019 年冠状病毒病（COVID-19）的胸部 CT 与 RT-PCR 检测的相关性：1014 例报告。
Radiology. 2020 Aug;296(2):E32-E40. doi: 10.1148/radiol.2020200642. Epub 2020 Feb 26.
7
Dengue plaque reduction neutralization test (PRNT) in primary and secondary dengue virus infections: How alterations in assay conditions impact performance.原发性和继发性登革病毒感染中的登革热蚀斑减少中和试验（PRNT）：检测条件的改变如何影响检测性能。
Am J Trop Med Hyg. 2009 Nov;81(5):825-33. doi: 10.4269/ajtmh.2009.08-0625.
Zotero 插件